breast cancer phenotype
Evidence from:
primary |
all sources
Related entities (36)
Mentioned in (276)
Papers in which this entity is mentioned.
- A guide to transcriptomic deconvolution in cancer. (2026)
- Comprehensive repertoire of the chromosomal alteration and mutational signatures across 16 cancer types. (2026)
- Artificial Intelligence agents for biological research: a survey. (2026)
- Whole-genome landscapes of 1,364 breast cancers. (2026)
- Whole genome sequencing approach to assess homologous recombination deficiency in a pan-cancer cohort. (2026)
- Nanopore-based cell-free DNA fragmentation and methylation profiles from the cerebral spinal fluid of patients with lung cancer brain metastases. (2025)
- FET fusion oncoproteins disrupt physiologic DNA repair and create a targetable opportunity for ATR inhibitor therapy. (2025)
- Rapid brain tumor classification from sparse epigenomic data. (2025)
- Chromosomal instability as a driver of cancer progression. (2025)
- Functional analysis of cancer-associated germline risk variants. (2025)
- Three-dimensional genome landscape of primary human cancers. (2025)
- Flexynesis: A deep learning toolkit for bulk multi-omics data integration for precision oncology and beyond. (2025)
- High-Parameter Spatial Multi-Omics through Histology-Anchored Integration (2025)
- Transcription start sites experience a high influx of heritable variants fueled by early development. (2025)
- Tumor-informed deep sequencing of ctDNA detects minimal residual disease and predicts relapse in osteosarcoma. (2024)
- Principles and methods for transferring polygenic risk scores across global populations. (2024)
- CAGI, the Critical Assessment of Genome Interpretation, establishes progress and prospects for computational genetic variant interpretation methods. (2024)
- Transient loss of Polycomb components induces an epigenetic cancer fate. (2024)
- Recent advances in polygenic scores: translation, equitability, methods and FAIR tools. (2024)
- Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme. (2024)
- Analysis of 10,478 cancer genomes identifies candidate driver genes and opportunities for precision oncology. (2024)
- The Application of Long-Read Sequencing to Cancer. (2024)
- A New Era of Data-Driven Cancer Research and Care: Opportunities and Challenges. (2024)
- ENPP1 Immunobiology as a Therapeutic Target. (2023)
- Combination of genomic instability score and TP53 status for prognosis prediction in lung adenocarcinoma. (2023)
- A Novel Tissue-Free Method to Estimate Tumor-Derived Cell-Free DNA Quantity Using Tumor Methylation Patterns. (2023)
- Comprehensive repertoire of the chromosomal alteration and mutational signatures across 16 cancer types from 10,983 cancer patients (2023)
- GCparagon: evaluating and correcting GC biases in cell-free DNA at the fragment level. (2023)
- Predicting tumour content of liquid biopsies from cell-free DNA. (2023)
- Heritable defects in telomere and mitotic function selectively predispose to sarcomas. (2023)
- Biobank-scale methods and projections for sparse polygenic prediction from machine learning. (2023)
- Machine learning for genetics-based classification and treatment response prediction in cancer of unknown primary. (2023)
- Validation of the new EPIC DNA methylation microarray (900K EPIC v2) for high-throughput profiling of the human DNA methylome. (2023)
- Osteoclasts in Osteosarcoma: Mechanisms, Interactions, and Therapeutic Prospects. (2023)
- Polygenic scoring accuracy varies across the genetic ancestry continuum. (2023)
- Towards understandings of serine/arginine-rich splicing factors. (2023)
- RNA splicing dysregulation and the hallmarks of cancer. (2023)
- Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA. (2022)
- At the dawn: cell-free DNA fragmentomics and gene regulation. (2022)
- Single-cell analysis of somatic mutations in human bronchial epithelial cells in relation to aging and smoking. (2022)
- Genome-wide mutational signatures in low-coverage whole genome sequencing of cell-free DNA. (2022)
- Cellpose 2.0: how to train your own model. (2022)
- Explainable multiview framework for dissecting spatial relationships from highly multiplexed data. (2022)
- Human Retrotransposons and Effective Computational Detection Methods for Next-Generation Sequencing Data. (2022)
- Variant interpretation using population databases: Lessons from gnomAD. (2022)
- Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression. (2022)
- Single-cell genomic variation induced by mutational processes in cancer. (2022)
- Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533. (2022)
- Beneficial Effects of Betaine: A Comprehensive Review. (2021)
- Integrating molecular profiles into clinical frameworks through the Molecular Oncology Almanac to prospectively guide precision oncology. (2021)
- Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA. (2021)
- Nanopore sequencing technology, bioinformatics and applications. (2021)
- Autosomal sex-associated co-methylated regions predict biological sex from DNA methylation. (2021)
- Application of third-generation sequencing in cancer research. (2021)
- Alternative splicing: Human disease and quantitative analysis from high-throughput sequencing. (2021)
- Evaluating the transcriptional fidelity of cancer models. (2021)
- A practical guide to cancer subclonal reconstruction from DNA sequencing. (2021)
- Therapeutic Implications of Germline Testing in Patients With Advanced Cancers. (2021)
- Integrative reconstruction of cancer genome karyotypes using InfoGenomeR. (2021)
- Detection and characterization of lung cancer using cell-free DNA fragmentomes. (2021)
- kataegis: an R package for identification and visualization of the genomic localized hypermutation regions using high-throughput sequencing. (2021)
- Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases. (2021)
- Macrophage Polarization States in the Tumor Microenvironment. (2021)
- Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. (2021)
- Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity. (2021)
- Polygenic risk scores: from research tools to clinical instruments. (2020)
- DNA mismatch repair promotes APOBEC3-mediated diffuse hypermutation in human cancers. (2020)
- Immuno-genomic landscape of osteosarcoma. (2020)
- Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring. (2020)
- Pan-cancer analysis of whole genomes. (2020)
- Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases. (2020)
- Distinct Classes of Complex Structural Variation Uncovered across Thousands of Cancer Genome Graphs. (2020)
- Inferring structural variant cancer cell fraction. (2020)
- Emerging Roles of SRSF3 as a Therapeutic Target for Cancer. (2020)
- Pan-cancer landscape of homologous recombination deficiency. (2020)
- Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma. (2020)
- Design Features for Improving Mobile Health Intervention User Engagement: Systematic Review and Thematic Analysis. (2020)
- Cancer PRSweb: An Online Repository with Polygenic Risk Scores for Major Cancer Traits and Their Evaluation in Two Independent Biobanks. (2020)
- Diverse noncoding mutations contribute to deregulation of cis-regulatory landscape in pediatric cancers. (2020)
- Neoadjuvant checkpoint blockade for cancer immunotherapy. (2020)
- Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors. (2020)
- Comprehensive analysis of structural variants in breast cancer genomes using single-molecule sequencing. (2020)
- Polygenic prediction via Bayesian regression and continuous shrinkage priors. (2019)
- Defining the Genetic, Genomic, Cellular, and Diagnostic Architectures of Psychiatric Disorders. (2019)
- CHASMplus Reveals the Scope of Somatic Missense Mutations Driving Human Cancers. (2019)
- Exploring the landscape of focal amplifications in cancer using AmpliconArchitect. (2019)
- Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy. (2019)
- Tumor mutational burden standardization initiatives: Recommendations for consistent tumor mutational burden assessment in clinical samples to guide immunotherapy treatment decisions. (2019)
- The Clonal Evolution of Metastatic Osteosarcoma as Shaped by Cisplatin Treatment. (2019)
- Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study. (2019)
- Germline variants associated with leukocyte genes predict tumor recurrence in breast cancer patients. (2019)
- Association of BRCA1- and BRCA2-deficiency with mutation burden, expression of PD-L1/PD-1, immune infiltrates, and T cell-inflamed signature in breast cancer. (2019)
- Genome-Informed Targeted Therapy for Osteosarcoma. (2019)
- Structural variant calling: the long and the short of it. (2019)
- Genome-wide cell-free DNA fragmentation in patients with cancer. (2019)
- RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues. (2019)
- Comprehensive analysis of structural variants in breast cancer genomes using single molecule sequencing (2019)
- Pan-cancer whole-genome analyses of metastatic solid tumours. (2019)
- The Cancer Spliceome: Reprograming of Alternative Splicing in Cancer. (2018)
- Driver Fusions and Their Implications in the Development and Treatment of Human Cancers. (2018)
- Detection of Somatic Structural Variants Enables Quantification and Characterization of Circulating Tumor DNA in Children With Solid Tumors. (2018)
- A fast detection of fusion genes from paired-end RNA-seq data. (2018)
- Quantification of subclonal selection in cancer from bulk sequencing data. (2018)
- Widespread Selection for Oncogenic Mutant Allele Imbalance in Cancer. (2018)
- Enhanced detection of circulating tumor DNA by fragment size analysis. (2018)
- Genome doubling shapes the evolution and prognosis of advanced cancers. (2018)
- Complex rearrangements and oncogene amplifications revealed by long-read DNA and RNA sequencing of a breast cancer cell line. (2018)
- Personal Cancer Genome Reporter: variant interpretation report for precision oncology. (2018)
- Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes. (2018)
- Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes (2018)
- Sensitivity to sequencing depth in single-cell cancer genomics. (2018)
- SvABA: genome-wide detection of structural variants and indels by local assembly. (2018)
- Patterns and mechanisms of structural variations in human cancer. (2018)
- Picky comprehensively detects high-resolution structural variants in nanopore long reads. (2018)
- Thymic involution and rising disease incidence with age. (2018)
- Nanopore Sequencing Reveals High-Resolution Structural Variation in the Cancer Genome (2017)
- ClonEvol: clonal ordering and visualization in cancer sequencing. (2017)
- OncoKB: A Precision Oncology Knowledge Base. (2017)
- SVclone: inferring structural variant cancer cell fraction (2017)
- HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures. (2017)
- The evolution of tumour phylogenetics: principles and practice. (2017)
- Universal Patterns of Selection in Cancer and Somatic Tissues. (2017)
- ChimeRScope: a novel alignment-free algorithm for fusion transcript prediction using paired-end RNA-Seq data. (2017)
- One-Carbon Metabolism in Health and Disease. (2017)
- Integrative clustering of multi-level 'omic data based on non-negative matrix factorization algorithm. (2017)
- Patient-derived xenografts undergo mouse-specific tumor evolution. (2017)
- Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumors. (2017)
- A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles. (2017)
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. (2017)
- GRIDSS: sensitive and specific genomic rearrangement detection using positional de Bruijn graph assembly. (2017)
- CScape: a tool for predicting oncogenic single-point mutations in the cancer genome. (2017)
- Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors. (2017)
- A method to reduce ancestry related germline false positives in tumor only somatic variant calling. (2017)
- The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog). (2017)
- Puberty and structural brain development in humans. (2017)
- ReMixT: clone-specific genomic structure estimation in cancer. (2017)
- Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype. (2017)
- Copy-number signatures and mutational processes in ovarian carcinoma (2017)
- Fast and Accurate Genomic Analyses using Genome Graphs (2017)
- Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin. (2016)
- B lymphocytes and cancer: a love-hate relationship. (2016)
- Visualizing tumor evolution with the fishplot package for R. (2016)
- Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer. (2016)
- Inhibition of Mammary Cancer Progression in Fetal Alcohol Exposed Rats by β-Endorphin Neurons. (2016)
- Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors. (2016)
- Fragment Length of Circulating Tumor DNA. (2016)
- DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution. (2016)
- Global analysis of somatic structural genomic alterations and their impact on gene expression in diverse human cancers. (2016)
- Landscape of somatic mutations in 560 breast cancer whole-genome sequences. (2016)
- Enacting the molecular imperative: How gene-environment interaction research links bodies and environments in the post-genomic age. (2016)
- Substantial contribution of extrinsic risk factors to cancer development. (2016)
- The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies. (2016)
- An Fgf-Shh signaling hierarchy regulates early specification of the zebrafish skull. (2016)
- Oxidative stress signaling to chromatin in health and disease. (2016)
- Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. (2016)
- APOBEC-induced mutations in human cancers are strongly enriched on the lagging DNA strand during replication. (2016)
- Development and clinical application of an integrative genomic approach to personalized cancer therapy. (2016)
- Epidemiology, Etiology, and Treatment of Isolated Cleft Palate. (2016)
- GenVisR: Genomic Visualizations in R. (2016)
- Detecting Genomic Signatures of Natural Selection with Principal Component Analysis: Application to the 1000 Genomes Data. (2016)
- Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. (2016)
- Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. (2015)
- Design and bioinformatics analysis of genome-wide CLIP experiments. (2015)
- Clock-like mutational processes in human somatic cells. (2015)
- CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelial-mesenchymal transition in hepatocellular carcinoma. (2015)
- The landscape of long noncoding RNAs in the human transcriptome. (2015)
- Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing. (2015)
- Activation of the FGFR-STAT3 pathway in breast cancer cells induces a hyaluronan-rich microenvironment that licenses tumor formation. (2014)
- Hidden Markov Model-Based CNV Detection Algorithms for Illumina Genotyping Microarrays. (2014)
- RADIA: RNA and DNA integrated analysis for somatic mutation detection. (2014)
- Genome-wide analysis of noncoding regulatory mutations in cancer. (2014)
- Distinct structural transitions of chromatin topological domains correlate with coordinated hormone-induced gene regulation. (2014)
- PVT1 dependence in cancer with MYC copy-number increase. (2014)
- Inference of high resolution HLA types using genome-wide RNA or DNA sequencing reads. (2014)
- Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3'-UTR landscape across seven tumour types. (2014)
- Screening tests: a review with examples. (2014)
- Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. (2014)
- Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis. (2014)
- Clonal evolution in hematological malignancies and therapeutic implications. (2014)
- Deconvolving tumor purity and ploidy by integrating copy number alterations and loss of heterozygosity. (2014)
- The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation. (2014)
- Inferring tumour purity and stromal and immune cell admixture from expression data. (2013)
- Rbfox proteins regulate alternative mRNA splicing through evolutionarily conserved RNA bridges. (2013)
- Cancer genome landscapes. (2013)
- THetA: inferring intra-tumor heterogeneity from high-throughput DNA sequencing data. (2013)
- Prioritizing Potentially Druggable Mutations with dGene: An Annotation Tool for Cancer Genome Sequencing Data. (2013)
- Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability. (2013)
- Ewing sarcoma protein: a key player in human cancer. (2013)
- Candidate gene association studies: a comprehensive guide to useful in silico tools. (2013)
- A mega-analysis of genome-wide association studies for major depressive disorder. (2013)
- A meta-analysis of two genome-wide association studies to identify novel loci for maximum number of alcoholic drinks. (2013)
- Alcohol exposure in utero increases susceptibility to prostate tumorigenesis in rat offspring. (2013)
- Visualizing genomic information across chromosomes with PhenoGram. (2013)
- Signatures of mutational processes in human cancer. (2013)
- Large-scale genotyping identifies 41 new loci associated with breast cancer risk. (2013)
- Effects of alcohol on the endocrine system. (2013)
- Emerging landscape of oncogenic signatures across human cancers. (2013)
- DGIdb: mining the druggable genome. (2013)
- RNA splicing: a new player in the DNA damage response. (2013)
- An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. (2013)
- Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells. (2013)
- Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. (2013)
- Pan-cancer patterns of somatic copy number alteration. (2013)
- The Genomic Revolution and Beliefs about Essential Racial Differences: A Backdoor to Eugenics? (2013)
- Gene-environment interactions in cancer epidemiology: a National Cancer Institute Think Tank report. (2013)
- Neuroprotective actions of perinatal choline nutrition. (2013)
- Absolute quantification of somatic DNA alterations in human cancer. (2012)
- Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. (2012)
- High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing. (2012)
- Myeloid cells in tumor inflammation. (2012)
- Managing incidental findings and research results in genomic research involving biobanks and archived data sets. (2012)
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. (2012)
- Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma. (2012)
- Mutational processes molding the genomes of 21 breast cancers. (2012)
- Microsatellites with macro-influence in ewing sarcoma. (2012)
- Chronic shift-lag alters the circadian clock of NK cells and promotes lung cancer growth in rats. (2012)
- Pathway analysis of genomic data: concepts, methods, and prospects for future development. (2012)
- Novel mutations target distinct subgroups of medulloblastoma. (2012)
- Vitamin D and its role during pregnancy in attaining optimal health of mother and fetus. (2012)
- The genetic basis of alcoholism: multiple phenotypes, many genes, complex networks. (2012)
- AID/APOBEC cytosine deaminase induces genome-wide kataegis. (2012)
- Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. (2012)
- Regulation of cancer progression by β-endorphin neuron. (2012)
- Patient-derived tumour xenografts as models for oncology drug development. (2012)
- Massive genomic rearrangement acquired in a single catastrophic event during cancer development. (2011)
- Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. (2011)
- BRCA1 and BRCA2: different roles in a common pathway of genome protection. (2011)
- Regulation of chromatin by histone modifications. (2011)
- Outlier-Based Differential Expression Analysis in Proteomics Studies. (2011)
- Functional consequences of developmentally regulated alternative splicing. (2011)
- Gene set analysis of genome-wide association studies: methodological issues and perspectives. (2011)
- Cleft lip and palate: understanding genetic and environmental influences. (2011)
- Significant differences in global genomic DNA methylation by gender and race/ethnicity in peripheral blood. (2011)
- Copy number variation detection in whole-genome sequencing data using the Bayesian information criterion. (2011)
- Mechanisms and consequences of alternative polyadenylation. (2011)
- Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. (2011)
- Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography-tandem mass spectrometry. (2011)
- Molecular mechanisms of long noncoding RNAs. (2011)
- Trans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate genes, with a major role for the HLA. (2011)
- Distribution of allele frequencies and effect sizes and their interrelationships for common genetic susceptibility variants. (2011)
- The neuronal transporter gene SLC6A15 confers risk to major depression. (2011)
- Control-free calling of copy number alterations in deep-sequencing data using GC-content normalization. (2011)
- Allele-specific copy number analysis of tumors. (2010)
- Integrative analysis of the melanoma transcriptome. (2010)
- Statistical analysis strategies for association studies involving rare variants. (2010)
- Fetal alcohol exposure increases mammary tumor susceptibility and alters tumor phenotype in rats. (2010)
- Network of Cancer Genes: a web resource to analyze duplicability, orthology and network properties of cancer genes. (2010)
- Association study of 182 candidate genes in anorexia nervosa. (2010)
- rSW-seq: algorithm for detection of copy number alterations in deep sequencing data. (2010)
- In vivo magnetic resonance spectroscopy: basic methodology and clinical applications. (2010)
- Cellular metabolic stress: considering how cells respond to nutrient excess. (2010)
- The genetic interpretation of area under the ROC curve in genomic profiling. (2010)
- A review of estrogen receptor alpha gene (ESR1) polymorphisms, mood, and cognition. (2010)
- The epigenetics of sex differences in the brain. (2009)
- The histone gene activator HINFP is a nonredundant cyclin E/CDK2 effector during early embryonic cell cycles. (2009)
- Recurring mutations found by sequencing an acute myeloid leukemia genome. (2009)
- Choline: an essential nutrient for public health. (2009)
- On the value of homogeneous constructs for construct validation, theory testing, and the description of psychopathology. (2009)
- Genomewide association studies: history, rationale, and prospects for psychiatric disorders. (2009)
- Fewer permutations, more accurate P-values. (2009)
- Peroxisome proliferator-activated receptor and retinoic x receptor in alcoholic liver disease. (2009)
- Discrimination and racial disparities in health: evidence and needed research. (2009)
- Genome-wide and candidate gene association study of cigarette smoking behaviors. (2009)
- Common and rare variants in multifactorial susceptibility to common diseases. (2008)
- Circulating microRNAs as stable blood-based markers for cancer detection. (2008)
- Model-based analysis of ChIP-Seq (MACS). (2008)
- 3' end mRNA processing: molecular mechanisms and implications for health and disease. (2008)
- Model-based analysis of ChIP-Seq (MACS). (2008)
- Model-based analysis of ChIP-Seq (MACS). (2008)
- Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. (2008)
- Effect of in utero and early-life conditions on adult health and disease. (2008)
- Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. (2007)
- Competing interactions between micro-RNAs determine neural progenitor survival and proliferation after ethanol exposure: evidence from an ex vivo model of the fetal cerebral cortical neuroepithelium. (2007)
- SNPs3D: candidate gene and SNP selection for association studies. (2006)
- Alcohol, hormones, and postmenopausal women. (1998)
- Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain. (1996)
Merged raw entities (10)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| breast cancer | phenotype | 268 | 1006 |
| breast carcinoma | phenotype | 15 | 37 |
| breast | phenotype | 7 | 7 |
| breast cancer cells | phenotype | 4 | 4 |
| breast cancers | phenotype | 4 | 4 |
| invasive breast cancer | phenotype | 4 | 4 |
| bc | phenotype | — | — |
| brca1-associated breast cancer | phenotype | — | — |
| brca2-associated breast cancer | phenotype | — | — |
| breast cancer susceptibility | phenotype | — | — |